Antioxidant therapy in Alzheimer's disease: theory and practice
- PMID: 18991755
- PMCID: PMC2921812
- DOI: 10.2174/138955708786369582
Antioxidant therapy in Alzheimer's disease: theory and practice
Abstract
Alzheimer disease treatment has yet to yield a successful therapy that addresses the source of the damage found in brains. Of the varied proposed theories of AD etiology, reactive oxygen species (ROS) generation is cited as a common factor. Efforts to reduce the pathology associated with ROS via antioxidants therefore offer new hope to patients suffering from this devastative disease.
Similar articles
-
The potential role of nanoyttria in alleviating oxidative stress biomarkers: Implications for Alzheimer's disease therapy.Life Sci. 2020 Oct 15;259:118287. doi: 10.1016/j.lfs.2020.118287. Epub 2020 Aug 16. Life Sci. 2020. PMID: 32814066 Review.
-
Inhibition of early upstream events in prodromal Alzheimer's disease by use of targeted antioxidants.Curr Aging Sci. 2014;7(2):77-90. doi: 10.2174/1874609807666140804115633. Curr Aging Sci. 2014. PMID: 25101711 Review.
-
Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside.Mol Neurobiol. 2022 Jan;59(1):657-680. doi: 10.1007/s12035-021-02617-1. Epub 2021 Nov 9. Mol Neurobiol. 2022. PMID: 34751889 Review.
-
Targeting Free Radicals in Oxidative Stress-Related Human Diseases.Trends Pharmacol Sci. 2017 Jul;38(7):592-607. doi: 10.1016/j.tips.2017.04.005. Epub 2017 May 24. Trends Pharmacol Sci. 2017. PMID: 28551354 Review.
-
Antioxidant treatment in Alzheimer's disease: current state.J Mol Neurosci. 2003;21(1):1-11. doi: 10.1385/JMN:21:1:1. J Mol Neurosci. 2003. PMID: 14500988 Review.
Cited by
-
Effects of Essential Oil of Satureja bachtiarica Bunge in a Rat Model of Reserpine-Induced Depression.Iran J Med Sci. 2018 Jul;43(4):409-415. Iran J Med Sci. 2018. PMID: 30046210 Free PMC article.
-
Role of the transcription factor NRF2 in maintaining the integrity of the Blood-Brain Barrier.Fluids Barriers CNS. 2024 Nov 21;21(1):93. doi: 10.1186/s12987-024-00599-5. Fluids Barriers CNS. 2024. PMID: 39574123 Free PMC article. Review.
-
Natural products as a source of Alzheimer's drug leads.Nat Prod Rep. 2011 Jan;28(1):48-77. doi: 10.1039/c0np00027b. Epub 2010 Nov 12. Nat Prod Rep. 2011. PMID: 21072430 Free PMC article. Review.
-
Oxidative Stress Occurs Prior to Amyloid Aβ Plaque Formation and Tau Phosphorylation in Alzheimer's Disease: Role of Glutathione and Metal Ions.ACS Chem Neurosci. 2023 Sep 6;14(17):2944-2954. doi: 10.1021/acschemneuro.3c00486. Epub 2023 Aug 10. ACS Chem Neurosci. 2023. PMID: 37561556 Free PMC article. Review.
-
Amentoflavone Ameliorates Aβ1-42-Induced Memory Deficits and Oxidative Stress in Cellular and Rat Model.Neurochem Res. 2018 Apr;43(4):857-868. doi: 10.1007/s11064-018-2489-8. Epub 2018 Feb 6. Neurochem Res. 2018. PMID: 29411261
References
-
- Mayeux R. Epidemiology of neurodegeneration. Annu Rev Neurosci. 2003;26:81–104. - PubMed
-
- Selkoe DJ. The genetics and molecular pathology of Alzheimer’s disease: roles of amyloid and the presenilins. Neurol Clin. 2000;18:903–22. - PubMed
-
- Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci. 2001;24:1121–59. - PubMed
-
- McGeer PL, McGeer EG. Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging. 2001;22:799–809. - PubMed
-
- Weiner HL, Selkoe DJ. Inflammation and therapeutic vaccination in CNS diseases. Nature. 2002;420:879–84. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical